Concepedia

Chad R. Irwin

CR

Statistics

Publications

9

Citations

254

H-Index

9

Active since

2008

Affiliations

University of Alberta(Current)

Bristol-Myers Squibb (United States)

United States Military Academy

United States Food and Drug Administration

Health Canada

Chad R. Irwin is an author at University of Alberta specializing in virology, molecular virology, and life sciences.

Publications per year

2008–2023

9

Publications

9

Vaccinia Virus DNA Ligase Recruits Cellular Topoisomerase II to Sites of Viral Replication and Assembly

Yi-Chan Lin, Jianhong Li, Chad R. Irwin et al. · Journal of Virology · 2008 · 59 citations · Full text

, , +15

Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti‐tumor immunity with superior safety in bladder cancer models

Kyle Potts, Chad R. Irwin, Nicole A. Favis et al. · EMBO Molecular Medicine · 2017 · 49 citations · Full text

, , +17

In-Fusion® Cloning with Vaccinia Virus DNA Polymerase

Chad R. Irwin, Andrew Farmer, David O. Willer et al. · Methods in molecular biology · 2012 · 47 citations

, , +14

Modulation of the Myxoma Virus Plaque Phenotype by Vaccinia Virus Protein F11

Chad R. Irwin, David H. Evans · Journal of Virology · 2012 · 24 citations · Full text

, , +13

2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline &amp; Global Harmonization; Hybrid Assays; Oligonucleotides &amp; ADC; Non-Liquid &amp; Rare Matrices; Regulatory Inputs ( <u>Part 1A</u> – Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline &amp; Global Harmonization <u>Part 1B</u> - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/CDx/BAV, Immunogenicity, Gene &amp; Cell Therapy and Vaccine)

Matt Szapacs, Wenying Jian, Daniel S. Spellman et al. · Bioanalysis · 2023 · 17 citations

, , +13

1–5 of 9